Manu Jain MD MSc
Critical Care Medicine, Pleural Disease
Professor in Medicine-Pulmonary and Pediatrics, Northwestern University Medical School
Join to view full profile
676 N. St ClaireChicago, IL 60611
Phone+1 312-695-1800
Dr. Jain is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Manu Jain is a pulmonologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Northwestern Memorial Hospital, Jesse Brown Veterans Affairs Medical Center, Ann & Robert H. Lurie Children’s Hospital of Chicago, and Loyola Medicine. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice 28 years. He specializes in critical care medicine and pleural disease and is experienced in bronchiectasis, cystic fibrosis, and critical care medicine.
Education & Training
University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995- University of ChicagoResidency, Internal Medicine, 1989 - 1992
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989
Certifications & Licensure
IL State Medical License 1992 - 2029
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013, 2015-2016
- CMS Meaningful Use Stage 2 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2011, 2013, 2015-2016
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2011, 2013, 2015-2016
Clinical Trials
- A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD Start of enrollment: 2010 Oct 07
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation
- Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) Start of enrollment: 2016 Oct 21
Publications & Presentations
PubMed
- Within-Person Sweat Chloride Variability in People with Cystic Fibrosis Measured via Wearable Microfluidic Sticker.Melissa H Ross, Thaddeus Cybulski, Rachel S Nelson, Roozbeh Ghaffari, John A Rogers
Annals of the American Thoracic Society. 2026-08-04 - Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.Jennifer S Guimbellot, Elizabeth Baker, Ashritha Chalamalla, Natalie R Rose, Lloyd J Edwards
The European Respiratory Journal. 2026-07-02 - Single-cell RNAseq identifies persistent epithelial and immune dysfunction in PwCF by mitigating inter-individual sampling heterogeneity.Thaddeus Cybulski, Marc A Sala, Trevor Nicholson, Zasu Klug, Rachel Nelson
Journal of Cystic Fibrosis. 2026-05-01
Press Mentions
Fluorescent Contrast Agent Noninvasively Identifies Common Skin CancerAugust 22nd, 2025- New Wireless Sweat Patch May Improve Cystic Fibrosis TreatmentAugust 18th, 2025
- Epicore Launches Wearable Patch to Analyze Sweat of CF PatientsOctober 7th, 2021
Grant Support
- Mitochondrial metabolism as a therapeutic target in pulmonary fibrosisJESSE BROWN VA MEDICAL CENTER2010–2028
- 7th Annual Workshop on Confocal Microscopy for Cutaneous DiagnosticsSLOAN-KETTERING INST CAN RESEARCH2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
